Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids

Molecular Pharmacology

Volumn 68, Issue 4, 2005, Pages 1018-1030

  Won, Jun Lee ^a   Shim, Joong Youn ^b   Zhu, Bao Ting ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFLAVONOID; CATECHIN; CATECHOL METHYLTRANSFERASE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FISETIN; GALLIC ACID; MAGNESIUM ION; METHYLTRANSFERASE INHIBITOR; MYRICETIN; POLYPHENOL DERIVATIVE; QUERCETIN; S ADENOSYLHOMOCYSTEINE;

ARTICLE; BINDING AFFINITY; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA METHYLATION; ENZYME BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; KINETICS; MATHEMATICAL MODEL; MOLECULAR MODEL; MOLECULAR STABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROKARYOTE; TEA;

CATECHIN; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; KINETICS; PROMOTER REGIONS (GENETICS); TEA;

EID: 25144507259     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.008367     Document Type: Article

References (39)

1. Aparicio A, Eads CA, Leong LA, Laird PW, Newman EM, Synold TW, Baker SD, Zhao M, and Weber JS (2003) Phase I trial of continuous infusion 5-aza-2′ -deoxycytidine. Cancer Chemother Pharmacol 51:231-239.
2. Bestor TH and Ingram VM (1983) Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity and mode of interaction with DNA. Proc Natl Acad Sci USA 80:5559-5563.
3. Bovenzi V and Momparler RL (2001) Antineoplastic action of 5-aza-2′ -deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells. Cancer Chemother Pharmacol 48:71-76.
4. Bowie JU, Lüthy R, and Eisenberg D (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science (Wash DC) 253:164-170.
5. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, and Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature (Lond) 395:89-93.
6. Dauber-Osguthorpe P, Roberts VA, Osguthorpe DJ, Wolff J, Genest M, and Hagler AT (1998) Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins 4:31-47.
7. Ding HQ, Karasawa N, and Goddard WA 3rd (1992) Atomic level simulations on a million particles: The cell multipole method for Coulomb and London nonbond interactions. J Chem Phys 97:4309-4315.
8. Dudev T and Lim C (2003) Principles governing Mg, Ca and Zn binding and selectivity in proteins. Chem Rev 103:773-787.
9. Eads CA, Nickel AE, and Laird PW (2002) Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic mice. Cancer Res 62:1296-1299.
10. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427-5440.
11. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, and Yang CS (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced gene in cancer cell lines. Cancer Res 63:7563-7570.
12. Fiser A, Do RK, and Sali A (2000) Modeling of loops in protein structures. Protein Sci 9:1753-1773.
13. Higgins DG, Thompson JD, and Gibson TJ (1996) Using CLUSTAL for multiple sequence alignments. Methods Enzymol 266:383-402.
14. James SJ, Melnyk S, Pogribna M, Pogribny IP, and Caudill MA (2003) Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132:2361s-2366s.
15. Jones PA and Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428.
16. Jones PA and Takai D (2001) The role of DNA methylation in mammalian epigenetics. Science (Wash DC) 293:1068-1070.
17. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, and Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205.
18. Lichtenstein AV and Kisseljova NP (2001) DNA methylation and carcinogenesis. Biochemistry (Mosc) 66:235-255.
19. Liu ZJ and Zhu BT (2004) Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem Mol Biol 88:265-275.
20. Lu YP, Lou YR, Lin Y, Shih WJ, Huang MT, Yang CS, and Conney AH (2001) Inhibitory effects of orally administered green tea, black tea and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res 61:5002-5009.
21. Martin JL and McMillan FM (2002) SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. Curr Opin Struct Biol 12:783-793.
22. Okano M, Xie S, and Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19:219-220.
23. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, and Belinsky SA (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954-5958.
24. Press WH, Teukolsky SA, Vetterling WT, and Flanery BP (1993) Numerical Recipes: The Art of Scientific Computing, pp 420-424, Cambridge University Press, Cambridge.
25. Renbaum P, Abrahamove D, Fainsod A, Wilson GG, Rottem S, and Razin A (1990) Cloning, characterization and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1(M.SssI). Nucleic Acids Res 18:1145-1152.
26. Saunders N, Dicker A, Popa C, Jones S, and Dahler A (1999) Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res 59:399-404.
27. Schubert HL, Blumenthal RM, and Cheng X (2003) Many paths to methyltransfer: a chronicle of convergence. Trends Biochem Sci 28:329-335.
28. Shaker S, Bernstein M, Momparler LF, and Momparler RL (2003) Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′- deoxycytidine) and histone deacetylation (trichostatin A, depsipetide) in combination against myeloid leukemic cells. Leuk Res 27:437-444.
29. Shi H, Wei SH, Leu YW, Rahmatpanah F, Liu JC, Yan PS, Nephew KP, and Huang TH (2003) Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation and histone acetylation. Cancer Res 63:2164-2171.
30. Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S, and Sacchi N (2000) Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene 19:1556-1563.
31. Stewart JJP (1989) Optimization of parameters for semiempirical methods. I. Method. J Comp Chem 10:209-220.
32. Vidgren J, Svensson LA, and Liljas A (1994) Crystal structure of catechol Omethyltransferase. Nature (Lond) 368:354-358.
33. Wainfan E and Poirier LA (1992) Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 52:2071s-2077s.
34. Yoshida M, Furumai R, Nishiyama M, Komatsu Y, Nishino N, and Horinouchi S (2001) Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol 48 (Suppl 1):S20-S26.
35. Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ, and Hornby DP (2002) Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol 321:591-599.
36. Zhu BT, Ezell EL, and Liehr JG (1996) Catechol-O-methyltransferase- catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem 269:292-299.
37. Zhu BT and Liehr JG (1996) Inhibition of catechol O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiolinduced tumorigenesis. J Biol Chem 271:1357-1363.
38. Zhu BT, Patel UK, Cai MX, and Conney AH (2000) O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab Dispos 28:1024-1030.
39. Zhu BT, Patel UK, Cai MX, Lee AJ, and Conney AH (2001) Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-Omethyltransferase. Xenobiotica 31:879-890.